In line with in silico, in vitro studies showed that a significant pattern of reduction or suppression of HIF-1A, EGFR tyrosine kinase, and HER2 was observed in MCF-7 cancer cells given EAE treatment (p < 0.05; Figure 3). Here, ERBB2 is linked to cancer.